Clinical trial · Observational
Consent for Obtaining Additional Tissue at the Time of a Diagnostic Biopsy
NCT01078350CI-TRIAL-00030422completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is designed to collect tissue samples that may aid in the treatment and learning about various oncology diagnosis.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hodgkin Disease | Hodgkin Lymphoma | ALIAS | 0.90 |
| Lymphoma | Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| phlebotomy | Procedure | — | UNRESOLVED |
| tumor tissue aspiration | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Further analysis
- timeFrame
- at collection time
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 21 Years
Show eligibility criteria text
Inclusion Criteria: * Subjects who are having a tissue procedure done as part of their standard oncology work-up will be eligible to be consented on this study. Exclusion Criteria: * None.
References
Publications (0)
Data not yet available
No reference posted for this study.